Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers
Status:
Completed
Trial end date:
2017-03-29
Target enrollment:
Participant gender:
Summary
EuRhythDia II is a multicenter, randomized, double-blind controlled study. The rationale of
EuRhythdia is to explore the effects of 12 weeks of timed melatonin treatment on circadian
rhythm, metabolic control and cardiovascular function in night shift workers. The 12 weeks of
intervention will be followed by 12 weeks of washing out.